SCHEMBL1484008

SCHEMBL1484008

COc1ccc2cc(-c3ccc(-n4ccnc4)nc3)[nH]c2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 2/20 0.48
CYP11B2 P19099 1/20 0.48
MAPT P10636 4/20 0.46
TDP1 Q9NUW8 3/20 0.46
LMNA P02545 2/20 0.46
CYP1A2 P05177 2/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2D6 P10635 2/20 0.46
CYP2C19 P33261 2/20 0.46
TP53 P04637 1/20 0.46
MAPK1 P28482 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
KDM4E B2RXH2 4/20 0.43
ITK Q08881 4/20 0.43
ALDH1A1 P00352 2/20 0.43
CCNB2 O95067 2/20 0.43
CDK1 P06493 2/20 0.43
CCNB1 P14635 2/20 0.43
CCNB3 Q8WWL7 2/20 0.43
AURKA O14965 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1424611 0.91 MAPT (0.49) CYP11B1CYP11B2MAPTTDP1LMNA
SCHEMBL1484074 0.85 GAA (0.42) MAPTTDP1LMNACYP1A2CYP3A4
SCHEMBL1484244 0.84 CYP19A1 (0.43) CYP11B1CYP11B2CYP3A4FLT3MAOA
SCHEMBL1422658 0.83 PIM1 (0.40) MAPTTDP1LMNACYP1A2CYP3A4
SCHEMBL13577817 0.83 PIM1 (0.40) MAPTTDP1LMNACYP1A2CYP3A4
SCHEMBL1422576 0.80 MAPT (0.41) MAPTSMN1; SMN2KDM4EITKALDH1A1
SCHEMBL1421155 0.80 CYP19A1 (0.46) TDP1CYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL1483709 0.79 GAA (0.42) MAPTTDP1LMNACYP1A2CYP3A4
SCHEMBL1422916 0.77 CYP1A1 (0.45) MAPTTDP1LMNACYP1A2CYP3A4
SCHEMBL1484023 0.77 TNKS (0.56) AURKAPLK4KDRFLT3AURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110076230-A1 Novel Substituted Indoles MERCK & CO. INC. 2011-03-31 US claimed
US-20110076230-A1 Novel Substituted Indoles MERCK & CO. INC. 2011-03-31 US disclosed
US-20110076230-A1 Novel Substituted Indoles MERCK & CO. INC. 2011-03-31 US disclosed
US-20110076230-A1 Novel Substituted Indoles MERCK & CO. INC. 2011-03-31 US disclosed
WO-2009155024-A1 NOVEL SUBSTITUTED INDOLES MERCK & CO., INC. (US) 2009-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110076230-A1 Novel Substituted Indoles APP, BACE1, PSEN1 CYP11B1 1163/4885CYP11B2 1183/4885MAPT 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.